Targovax to present at forthcoming conferences OSLO,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Targovax to present at forthcoming conferences

OSLO, Norway, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Targovax (OSE: TRVX, or "the Company"), a clinical stage company developing targeted immunotherapy treatments for cancer patients, announces that members of its senior management will present at the following conferences:

Nordic Life Science Days Date: 14 September 2016 Participants: Gunnar Gårdemyr (CEO) and Peter Skorpil (VP BD) Presentation time: 17:15 CET Venue: Waterfront Congress Center, Stockholm, Sweden

Sachs Associates: 16 th Annual Biotech in Europe forum Date: 28 September 2016 Participant: Gunnar Gårdemyr (CEO) Presentation time: 09:45 CET Venue: Congress Center, Basel, Switzerland

Cutting Edge / Oslo Innovation Week Date: 18 October 2016 Participant: Peter Skorpil (VP BD) Pre sentation time: 11:40 CET Venue: Oslo Science Park, Oslo, Norway

Teknologirevolusjon innen kreftterapi Date: 26 October 2016 Participant: Magnus Jaderberg (CMO) Presentation time: 11:20 CET Venue: Oslo Cancer Cluster, Oslo, Norway

Presentations will be available to download at www.targovax.com following these events.

For further information, please contact:

Gunnar Gårdemyr, CEO Phone: +46 73 083 77 79 Email: ggardemyr@targovax.com

Øystein Soug, CFO Phone: +47 90 6565 25 Email: oystein.soug@targovax.com

Media and IR enquires:

Jan Petter Stiff - Crux Advisors (Norway) Phone: +47 995 13 891 Email: jps@crux.no

Julia Phillips/Simon Conway - FTI Consulting (International) Phone: +44 20 3727 1000 Email: Targovax@FTIconsulting.com

About Targovax

Arming the patient's immune system to fight cancer

Targovax (OSE: TRVX) is a clinical stage immuno-oncology company developing targeted immunotherapy treatments for cancer patients. Targovax has a broad and diversified immune therapy portfolio and aims to become a world leader in its area. The company is currently developing two complementary and highly targeted approaches in immuno-oncology.

ONCOS - 102 is a virus-based immunotherapy platform based on engineered oncolytic viruses armed with potent immune-stimulating transgenes targeting solid tumors. This treatment is designed to reactivate the immune system's capacity to recognize and attack cancer cells.

TG01 and TG02 are part of a peptide-based immunotherapy platform targeting the difficult to treat RAS mutations found in more than 85% of pancreatic cancers, 50% of colorectal cancer and 20-30% of all cancers. Targovax is working towards demonstrating that TG vaccines will prolong time to cancer progression and increase survival.

These product candidates will be developed in combination with multiple treatments, including checkpoint inhibitors in several cancer indications. Targovax also has a number of other cancer immune therapy candidates in the early stages of development.

In July 2016 the Company listed its shares on Oslo Axess, securing funding for further development of the Company's ongoing and planned trials

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 361

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 281

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 220

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 163

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 150

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 104

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 217

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 275

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 174

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 298

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading

Top 5 Most Recently Viewed Articles

Veren Inc. Announces Quarterly Dividend Details for Investors

Updated Category News Views 123

Veren Inc. Dividend Announcement Veren Inc., also referred to as the Company, has made an exciting announcement regarding its quarterly cash dividend. This decision was reached by the Board of Directors, demonstrating a commitment to returning value to shareholders. The approved base dividend is set at $0.115 per share, a reflection of the Company's ongoing financial...

Continue Reading
Edible Garden's Organic Hydroponic Basil: A Revolutionary Launch

Updated Category News Views 212

Edible Garden Introduces USDA Organic Hydroponic Basil Edible Garden AG Incorporated, known for its leadership in controlled environment agriculture (CEA) and sustainable practices, has exciting news. The company has launched its USDA Certified Organic Hydroponic Basil Plant, available for retail. This innovative product merges two agricultural methods, hydroponic...

Continue Reading
Montage Partners Celebrates Equity Methods with Inaugural Award

Updated Category News Views 108

Montage Partners Recognizes Excellence with New Awards Program Montage Partners, a private equity firm focused on people-first strategies, has embarked on an exciting journey by introducing its inaugural Values Award. This award aims to shine a spotlight on high-performing portfolio companies and their exceptional leaders. The first company honored with this award is...

Continue Reading
Kuehn Law Advocates for Shareholders Amid Merger Investigations

Updated Category News Views 77

Kuehn Law's Commitment to Shareholders Kuehn Law, PLLC, located in New York, is a dedicated and responsive law firm specializing in shareholder litigation. The firm works closely with investors, guiding them through essential merger processes. With a strong emphasis on promoting justice, Kuehn Law focuses on identifying potential breaches in proposed mergers to guarantee...

Continue Reading
PMGC Holdings Inc. Transforms Its Business Landscape with New Name

Updated Category News Views 420

PMGC Holdings Inc. Transforms Its Business Landscape In a strategic move that signifies a bold shift in its corporate identity, PMGC Holdings Inc., formerly known as Elevai Labs Inc., has announced a significant rebranding and operational realignment. This exciting transition reflects the company's broader vision for the future and its commitment to exploring new...

Continue Reading